| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Chemotherapy for androgen-independent prostate cancer
|
Petrylak, Daniel P.
|
|
2005
|
23 |
1 |
p. 10-13
|
article
|
| 2 |
Clinical characterization of the prostatitis patient in Italy: a prospective urology outpatient study
|
Rizzo, Michelangelo
|
|
2004
|
23 |
1 |
p. 61-66
|
article
|
| 3 |
Endothelin receptor antagonists
|
Nelson, Joel B.
|
|
2005
|
23 |
1 |
p. 19-27
|
article
|
| 4 |
Immunotherapy with autologous antigen presenting cells for the treatment of androgen independent prostate cancer
|
Schellhammer, Paul F.
|
|
2005
|
23 |
1 |
p. 47-49
|
article
|
| 5 |
Impact of tumor size on the long-term survival of patients with early stage renal cell cancer
|
Kuczyk, M.
|
|
2005
|
23 |
1 |
p. 50-54
|
article
|
| 6 |
Mechanisms of the development of androgen independence in prostate cancer
|
So, Alan
|
|
2005
|
23 |
1 |
p. 1-9
|
article
|
| 7 |
Rationale for the development and current status of calcitriol in androgen-independent prostate cancer
|
Beer, Tomasz M.
|
|
2005
|
23 |
1 |
p. 28-32
|
article
|
| 8 |
Sacral colpopexy using mersilene mesh in the treatment of vaginal vault prolapse
|
Limb, Jerry
|
|
2004
|
23 |
1 |
p. 55-60
|
article
|
| 9 |
Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer
|
Chi, Kim N.
|
|
2005
|
23 |
1 |
p. 33-37
|
article
|
| 10 |
The role of bisphosphonates in hormone-refractory prostate cancer
|
Saad, Fred
|
|
2005
|
23 |
1 |
p. 14-18
|
article
|
| 11 |
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer
|
Gleave, Martin
|
|
2005
|
23 |
1 |
p. 38-46
|
article
|
Journal description